AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29880562 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-led home-education intervention with 5 home visits from a trained peer counsellor discussing infant care and nutrition.
Number of subjects: 12
Study 29880562 — intervention group
Group type: COMPARATOR
Intervention: Presence of paternal grandmothers during the intervention.
Number of subjects: 12
Study 29880562 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 12
Study 28704343 — intervention group
Group type: EXPERIMENTAL
Intervention: HIPP intervention
Number of subjects: 84
Study 28704343 — intervention group
Group type: COMPARATOR
Intervention: wellness contact control
Number of subjects: 84
Study 26207975 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight-bearing biofeedback training (part of standard-of-care rehabilitation)
Number of subjects: 26
Study 26207975 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care rehabilitation (control group)
Number of subjects: 26
Study 26207975 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight-bearing biofeedback training
Number of subjects: 26
Study 24106935 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow nasal cannulae (5 to 6 liters per minute)
Number of subjects: 303
Study 24106935 — intervention group
Group type: COMPARATOR
Intervention: Nasal CPAP (7 cm of water)
Number of subjects: 303
Study 24106935 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow nasal cannulae
Number of subjects: 303
Study 24106935 — intervention group
Group type: COMPARATOR
Intervention: Nasal CPAP
Number of subjects: 303
Study 20938636 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance exercise-training for 10 weeks
Number of subjects: 26
Study 20938636 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 26
Study 17713471 — intervention group
Group type: EXPERIMENTAL
Intervention: Lopinavir/ritonavir (LPV/RTV)
Number of subjects: 7
Study 17032094 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive processing therapy (CPT)
Number of subjects: 60
Study 17032094 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 60
Study 15107719 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 506
Study 15107719 — intervention group
Group type: COMPARATOR
Intervention: Citalopram
Number of subjects: 506
Study 11202838 — intervention group
Group type: EXPERIMENTAL
Intervention: Increase group (maintained EMG activity above 10 microV)
Number of subjects: 20
Study 11202838 — intervention group
Group type: COMPARATOR
Intervention: Decrease group (maintained EMG activity below 2 microV)
Number of subjects: 20
Study 11202838 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 20
Study 9287260 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg b.d. and clarithromycin 500 mg t.d.s. for two weeks (n = 27)
Number of subjects: 79
Study 9287260 — intervention group
Group type: EXPERIMENTAL
Intervention: De‐Nol 240 mg b.d. for four weeks, metronidazole 400 mg t.d.s. and amoxicillin 500 mg t.d.s. for one week (n = 26)
Number of subjects: 79
Study 9287260 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg b.d. and amoxicillin 500 mg t.d.s. for two weeks (n = 26)
Number of subjects: 79
Study 9287260 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional 'triple' therapy with bismuth and two antibiotics
Number of subjects: 79
Study 9287260 — intervention group
Group type: EXPERIMENTAL
Intervention: Hp eradication
Number of subjects: 79
Study 8320401 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive therapy with dietary adherence support from dietitians
Number of subjects: 0
Study 8320401 — intervention group
Group type: EXPERIMENTAL
Intervention: Role of dietitians in recruiting and selecting study volunteers
Number of subjects: 0
Study 8320401 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietitians' involvement in promoting dietary adherence
Number of subjects: 0
Study 3549320 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide 50 mg once daily + Ibuprofen 400 mg t.i.d. for 4 weeks
Number of subjects: 8
Study 3549320 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide 50 mg once daily + Diclofenac 25 mg t.i.d. for 4 weeks
Number of subjects: 8
Study 3549320 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide 50 mg once daily + Sulindac 200 mg b.i.d. for 4 weeks
Number of subjects: 8
Study 28901660 — intervention group
Group type: EXPERIMENTAL
Intervention: Local steroid injection
Number of subjects: 50
Study 28901660 — intervention group
Group type: COMPARATOR
Intervention: Wrist splinting
Number of subjects: 50
Study 26872281 — intervention group
Group type: EXPERIMENTAL
Intervention: Cephalometric measures in Class I patients
Number of subjects: 108
Study 26872281 — intervention group
Group type: EXPERIMENTAL
Intervention: Cephalometric measures in Class II patients
Number of subjects: 108
Study 26872281 — intervention group
Group type: COMPARATOR
Intervention: Objective measurements on lateral cephalograms
Number of subjects: 108
Study 24726507 — intervention group
Group type: EXPERIMENTAL
Intervention: Removal of cerclage
Number of subjects: 56
Study 24726507 — intervention group
Group type: COMPARATOR
Intervention: Retention of cerclage
Number of subjects: 56
Study 23817285 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing-led pain and symptom management intervention
Number of subjects: 0
Study 23817285 — intervention group
Group type: COMPARATOR
Intervention: Current usual care
Number of subjects: 0
Study 20575298 — intervention group
Group type: EXPERIMENTAL
Intervention: Guo's Maqian decoction (200 ml, twice daily for 8 weeks, followed by Guokangning capsule (0.44 g per capsule, 2 capsules, three times daily for 4 weeks))
Number of subjects: 114
Study 20575298 — intervention group
Group type: COMPARATOR
Intervention: Basic treatment including calcium supplementation and herb decoction
Number of subjects: 114
Study 18669951 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV infection
Number of subjects: 0
Study 18669951 — intervention group
Group type: COMPARATOR
Intervention: Highly active anti-retroviral therapy
Number of subjects: 0
Study 18669951 — intervention group
Group type: EXPERIMENTAL
Intervention: Other factors (e.g., reduced body mass index, suboptimal nutrition, anti-retroviral drugs)
Number of subjects: 0
Study 15992724 — intervention group
Group type: EXPERIMENTAL
Intervention: Irrigated catheter ablation
Number of subjects: 26
Study 15992724 — intervention group
Group type: COMPARATOR
Intervention: Standard catheter ablation
Number of subjects: 26
Study 15992724 — intervention group
Group type: EXPERIMENTAL
Intervention: All patients
Number of subjects: 26
Study 12891224 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxcarbazepine (30 to 46 mg/kg/day, given twice daily)
Number of subjects: 109
Study 12891224 — intervention group
Group type: COMPARATOR
Intervention: Carbamazepine
Number of subjects: 109
Study 12891224 — intervention group
Group type: COMPARATOR
Intervention: Phenobarbital
Number of subjects: 109
Study 12891224 — intervention group
Group type: COMPARATOR
Intervention: Phenytoin
Number of subjects: 109
Study 10566573 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 10 mg, titrated to 20 mg if necessary
Number of subjects: 177
Study 10566573 — intervention group
Group type: COMPARATOR
Intervention: Atorvastatin 10 mg, titrated to 20 mg if necessary
Number of subjects: 177
Study 10566573 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 177
Study 10566573 — intervention group
Group type: COMPARATOR
Intervention: Atorvastatin
Number of subjects: 177
Study 9499813 — intervention group
Group type: EXPERIMENTAL
Intervention: Bronchial histamine and methacholine challenges
Number of subjects: 10
Study 1809994 — intervention group
Group type: EXPERIMENTAL
Intervention: Lubor ampouls
Number of subjects: 0
Study 1809994 — intervention group
Group type: EXPERIMENTAL
Intervention: Lubor cream
Number of subjects: 0
Study 1809994 — intervention group
Group type: COMPARATOR
Intervention: Voltaren
Number of subjects: 0
Study 1809994 — intervention group
Group type: COMPARATOR
Intervention: Ketonal cream
Number of subjects: 0
Study 6340000 — intervention group
Group type: EXPERIMENTAL
Intervention: Fosfolip (calcium salt of phosphorylcholine chloride with pantethine) 3 capsules a day
Number of subjects: 50
Study 6340000 — intervention group
Group type: COMPARATOR
Intervention: Control group (25 checks)
Number of subjects: 50
Study 31260089 — intervention group
Group type: EXPERIMENTAL
Intervention: Eslicarbazepine acetate (ESL) adjunctive therapy (400‐1200 mg once daily)
Number of subjects: 1812
Study 31260089 — intervention group
Group type: EXPERIMENTAL
Intervention: Eslicarbazepine acetate (ESL) adjunctive therapy
Number of subjects: 1812
Study 31260089 — intervention group
Group type: EXPERIMENTAL
Intervention: Eslicarbazepine acetate (ESL) monotherapy (1200‐1600 mg once daily)
Number of subjects: 1812
Study 31260089 — intervention group
Group type: COMPARATOR
Intervention: Eslicarbazepine acetate (ESL)
Number of subjects: 1812
Study 29579102 — intervention group
Group type: EXPERIMENTAL
Intervention: Pills rich in n‐3 PUFA
Number of subjects: 99
Study 29579102 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study 27980393 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol (APAP) 2 g
Number of subjects: 40
Study 27980393 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 24172656 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapy-led exercise program (7 exercises daily for 12 weeks)
Number of subjects: 56
Study 24172656 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone injection followed by daily calf stretching
Number of subjects: 56
Study 23217397 — intervention group
Group type: EXPERIMENTAL
Intervention: IPC + GCS
Number of subjects: 108
Study 23217397 — intervention group
Group type: COMPARATOR
Intervention: GCS
Number of subjects: 108
Study 20716080 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine-tramadol (1 mg x kg(‐1))
Number of subjects: 60
Study 20716080 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine-neostigmine (2 microg x kg(‐1))
Number of subjects: 60
Study 17720116 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided facet joint injections
Number of subjects: 40
Study 17720116 — intervention group
Group type: COMPARATOR
Intervention: CT-controlled facet joint injections
Number of subjects: 40
Study 16385303 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed intramedullary nailing (Group I)
Number of subjects: 64
Study 16385303 — intervention group
Group type: COMPARATOR
Intervention: Open reduction and internal fixation with plates and screws (Group II)
Number of subjects: 64
Study 12087139 — intervention group
Group type: EXPERIMENTAL
Intervention: lopinavir-ritonavir (400 mg of lopinavir plus 100 mg of ritonavir twice daily)
Number of subjects: 653
Study 12087139 — intervention group
Group type: COMPARATOR
Intervention: nelfinavir (750 mg three times daily)
Number of subjects: 653
Study 10215095 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete forebrain commissurotomy (L.B.)
Number of subjects: 8
Study 10215095 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior callosotomy (D.K.)
Number of subjects: 8
Study 10215095 — intervention group
Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 8
Study 7833482 — intervention group
Group type: EXPERIMENTAL
Intervention: Reticulocyte indices
Number of subjects: 190
Study 7833482 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation between red cell and reticulocyte indices
Number of subjects: 190
Study 7833482 — intervention group
Group type: EXPERIMENTAL
Intervention: MCV ratio
Number of subjects: 190
Study 7833482 — intervention group
Group type: EXPERIMENTAL
Intervention: Inversion of MCV ratio
Number of subjects: 190
Study 7833482 — intervention group
Group type: EXPERIMENTAL
Intervention: Reticulocyte volume during marrow transplantation
Number of subjects: 190
Study 2798694 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly motivated subjects
Number of subjects: 232
Study 2798694 — intervention group
Group type: EXPERIMENTAL
Intervention: Lying (act of deception)
Number of subjects: 232
Study 2798694 — intervention group
Group type: COMPARATOR
Intervention: Verbal response (affirming, denying, repeating, or no verbal response)
Number of subjects: 232
Study 2798694 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated questions
Number of subjects: 232
Study 2798694 — intervention group
Group type: COMPARATOR
Intervention: Electrodermal measures
Number of subjects: 232
Study 355732 — intervention group
Group type: EXPERIMENTAL
Intervention: D-penicillamine
Number of subjects: 103
Study 355732 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 103
Study 30370532 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged exercise training (12-week program: resistance exercise twice per week, high intensity interval training once per week)
Number of subjects: 14
Study 27811523 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% concentration of fluorescein
Number of subjects: 22
Study 27811523 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% concentration of fluorescein
Number of subjects: 22
Study 27811523 — intervention group
Group type: COMPARATOR
Intervention: Both concentrations
Number of subjects: 22
Study 26093486 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar sealer
Number of subjects: 118
Study 23871417 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel (75 mg/m² every 21 days, intravenously) with Atrasentan (10 mg/day, orally)
Number of subjects: 994
Study 23871417 — intervention group
Group type: COMPARATOR
Intervention: Docetaxel (75 mg/m² every 21 days, intravenously) with Placebo
Number of subjects: 994
Study 23871417 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel with Atrasentan
Number of subjects: 994
Study 23871417 — intervention group
Group type: COMPARATOR
Intervention: Docetaxel with Placebo
Number of subjects: 994
Study 21825080 — intervention group
Group type: EXPERIMENTAL
Intervention: 17.5 mg once-weekly risedronate
Number of subjects: 272
Study 21825080 — intervention group
Group type: COMPARATOR
Intervention: Placebo (combined with daily 1000 IU of ergocalciferol)
Number of subjects: 272
Study 19309475 — intervention group
Group type: EXPERIMENTAL
Intervention: Exchange transfusion (XC)
Number of subjects: 20
Study 19309475 — intervention group
Group type: COMPARATOR
Intervention: Simple transfusion (ST)
Number of subjects: 20
Study 17080507 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin (40 mg IR formulation)
Number of subjects: 1
Study 17080507 — intervention group
Group type: COMPARATOR
Intervention: Optimized extraction method (control)
Number of subjects: 1
Study 15809368 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive atorvastatin to reduce LDL to <80 mg/dL (n=96)
Number of subjects: 300
Study 15809368 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive atorvastatin to reduce LDL to <80 mg/dL plus antioxidant vitamins C (1000 mg/d) and E (800 mg/d) (n=101)
Number of subjects: 300
Study 15809368 — intervention group
Group type: COMPARATOR
Intervention: Diet and low-dose lovastatin to reduce LDL to <130 mg/dL (n=103; control group)
Number of subjects: 300
Study 12197292 — intervention group
Group type: EXPERIMENTAL
Intervention: Stapling hemorrhoidectomy
Number of subjects: 90
Study 12197292 — intervention group
Group type: COMPARATOR
Intervention: Traditional surgery (open or closed)
Number of subjects: 90
Study 10211493 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (acupoint group)
Number of subjects: 60
Study 10211493 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-controlled analgesia with morphine (acupoint group)
Number of subjects: 60
Study 10211493 — intervention group
Group type: COMPARATOR
Intervention: Patient-controlled analgesia with morphine (control group)
Number of subjects: 60
Study 10211493 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative complications (acupoint group)
Number of subjects: 60
Study 10211493 — intervention group
Group type: COMPARATOR
Intervention: Postoperative complications (control group)
Number of subjects: 60
Study 7628595 — intervention group
Group type: COMPARATOR
Intervention: ZDV (500 mg daily) alone
Number of subjects: 60
Study 7628595 — intervention group
Group type: EXPERIMENTAL
Intervention: ZDV (500 mg daily) with folinic acid (15 mg daily) and intramuscular vitamin B12 (1000 micrograms monthly)
Number of subjects: 60
Study 7628595 — intervention group
Group type: EXPERIMENTAL
Intervention: ZDV (500 mg daily) with folinic acid and vitamin B12
Number of subjects: 60
Study 2703006 — intervention group
Group type: EXPERIMENTAL
Intervention: LMF + BCG
Number of subjects: 254
Study 2703006 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 254
Study 824172 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg sublingual isosorbide dinitrate
Number of subjects: 10
Study 824172 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 31576436 — intervention group
Group type: EXPERIMENTAL
Intervention: Levosimendan 0.2 µg/kg/min continuous infusion
Number of subjects: 39
Study 31576436 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 28177480 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy combined with bevacizumab (4 cycles of FEC followed by 4 cycles of docetaxel for HER2-negative tumours in BEVERLY-1; docetaxel and trastuzumab for HER2-positive tumours in BEVERLY-2)
Number of subjects: 152
Study 28177480 — intervention group
Group type: EXPERIMENTAL
Intervention: CTC detection at baseline (≥1 CTC/7.5 ml)
Number of subjects: 152
Study 28177480 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of pCR after neoadjuvant treatment with no CTC detection at baseline
Number of subjects: 152
Study 28177480 — intervention group
Group type: EXPERIMENTAL
Intervention: CEC level at baseline or variations during treatment
Number of subjects: 152
Study 25988734 — intervention group
Group type: EXPERIMENTAL
Intervention: Digitized tracing
Number of subjects: 20
Study 25988734 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital photography
Number of subjects: 20
Study 25988734 — intervention group
Group type: EXPERIMENTAL
Intervention: Both methods
Number of subjects: 20
Study 23176189 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide-formoterol pMDI without VHC
Number of subjects: 16
Study 23176189 — intervention group
Group type: COMPARATOR
Intervention: Budesonide-formoterol pMDI with VHC
Number of subjects: 16
Study 21440864 — intervention group
Group type: EXPERIMENTAL
Intervention: CD34+ transplantation (SC group)
Number of subjects: 55
Study 19401663 — intervention group
Group type: EXPERIMENTAL
Intervention: VAP technique (4 applications of 2 ml lidocaine 2% with oxygen flow of 3 l min(‐1))
Number of subjects: 34
Study 19401663 — intervention group
Group type: COMPARATOR
Intervention: STAN technique (insufflation of 3 l min(‐1) oxygen via nasal probe and two applications of 4 ml of lidocaine 2%)
Number of subjects: 34
Study 19401663 — intervention group
Group type: EXPERIMENTAL
Intervention: VAP technique
Number of subjects: 34
Study 15384821 — intervention group
Group type: EXPERIMENTAL
Intervention: NEPP regimen (1 exchange of Nutrineal, 1 exchange of Extraneal, 2 exchanges of Physioneal)
Number of subjects: 74
Study 15384821 — intervention group
Group type: COMPARATOR
Intervention: Standard PD (SPD) regimen (4 exchanges of Dianeal)
Number of subjects: 74
Study 10379018 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide (400 microg, twice daily)
Number of subjects: 1277
Study 10379018 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1277
Study 8924304 — intervention group
Group type: EXPERIMENTAL
Intervention: Health promotion programmes screened via closed circuit television in hospital waiting rooms
Number of subjects: 0
Study 8924304 — intervention group
Group type: COMPARATOR
Intervention: Normal television programmes screened on non-programme days
Number of subjects: 0
Study 2202199 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-aminosalicylic acid (5-ASA) suppositories, 400 mg bid
Number of subjects: 30
Study 2202199 — intervention group
Group type: COMPARATOR
Intervention: Placebo suppositories
Number of subjects: 30
Study 7225493 — intervention group
Group type: EXPERIMENTAL
Intervention: Disulfiram
Number of subjects: 30
Study 7225493 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 30849296 — intervention group
Group type: EXPERIMENTAL
Intervention: Caloric restriction plus exercise (CR + EX)
Number of subjects: 60
Study 30849296 — intervention group
Group type: COMPARATOR
Intervention: Exercise (EX) only
Number of subjects: 60
Study 27377616 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine/prilocaine cream
Number of subjects: 30
Study 27377616 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine/tetracaine cream
Number of subjects: 30
Study 26303453 — intervention group
Group type: EXPERIMENTAL
Intervention: Sexual health education (intervention group, n=30)
Number of subjects: 60
Study 26303453 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group, n=30)
Number of subjects: 60
Study 25251749 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual phone participation (IC)
Number of subjects: 257
Study 25251749 — intervention group
Group type: COMPARATOR
Intervention: Group phone participation (CC)
Number of subjects: 257
Study 25251749 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants with EDS
Number of subjects: 257
Study 25251749 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-depressant use (ADMs)
Number of subjects: 257
Study 25251749 — intervention group
Group type: EXPERIMENTAL
Intervention: High stress
Number of subjects: 257
Study 22926301 — intervention group
Group type: EXPERIMENTAL
Intervention: Circulating retinol
Number of subjects: 1433
Study 22926301 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E
Number of subjects: 1433
Study 22926301 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,25-dihydroxyvitamin D
Number of subjects: 1433
Study 22926301 — intervention group
Group type: EXPERIMENTAL
Intervention: 25-hydroxyvitamin D
Number of subjects: 1433
Study 22926301 — intervention group
Group type: EXPERIMENTAL
Intervention: Retinol levels
Number of subjects: 1433
Study 19322907 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunomodulators for patients at moderate risk of recurrence
Number of subjects: 0
Study 19322907 — intervention group
Group type: EXPERIMENTAL
Intervention: Biologic therapy (antitumor necrosis factor agents) for patients at highest risk of recurrence
Number of subjects: 0
Study 19322907 — intervention group
Group type: EXPERIMENTAL
Intervention: Colonoscopy 6-12 months after surgery
Number of subjects: 0